Skip to main content
logo
Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.690
-0.010 (-0.37%)
At close: Sep 18, 2026, 4:00 PM EDT
2.640
-0.050 (-1.86%)
After-hours: Sep 18, 2026, 7:48 PM EDT

Ovid Therapeutics Revenue

Ovid Therapeutics had revenue of $733.00K in the quarter ending June 30, 2026, a decrease of -88.31%. This brings the company's revenue in the last twelve months to $1.58M, down -76.20% year-over-year. In the year 2025, Ovid Therapeutics had annual revenue of $7.25M with 1,181.27% growth.

Revenue (ttm)
$1.58M
Revenue Growth
-76.20%
P/S Ratio
331.87
Revenue / Employee
$68,826
Employees
23
Market Cap
525.35M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.25M6.69M1,181.27%
Dec 31, 2024566.00K174.00K44.39%
Dec 31, 2023392.00K-1.11M-73.91%
Dec 31, 20221.50M-206.88M-99.28%
Dec 31, 2021208.38M195.77M1,551.57%
Dec 31, 202012.62M--
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Arvinas316.70M
REGENXBIO174.48M
Ginkgo Bioworks Holdings132.42M
Autolus Therapeutics117.39M
Assembly Biosciences74.85M
Prelude Therapeutics22.42M
Capricor Therapeutics11.13M
Prime Medicine4.07M
Revenue Rankings

OVID News

More News